Global Market for Body Composition Analyzers
Dublin, Aug. 24, 2022 (GLOBE NEWSWIRE) — The “Body Composition Analyzers – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Global Body Composition Analyzers Market to Reach $886.1 Million by 2026
The global market for Body Composition Analyzers estimated at US$623.8 Million in the year 2022, is projected to reach a revised size of US$886.1 Million by 2026, growing at a CAGR of 8.3% over the analysis period.
Of the various technologies used in analyzing body composition, bioimpedance analyzers represent the largest segment with a market share of around 42.5% of the market in value terms. The strength of bioimpedance analyzers lies in their ability to combine accuracy and prices, which are critical components in the area of body fat measurement.
Bio-Impedance Analyzers, one of the segments analyzed in the report, is projected to record a 9.6% CAGR and reach US$352 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Skinfold Calipers segment is readjusted to a revised 8.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $279.4 Million in 2022, While China is Forecast to Reach $94.3 Million by 2026
The Body Composition Analyzers market in the U.S. is estimated at US$279.4 Million in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$94.3 Million by the year 2026 trailing a CAGR of 10.4% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.5% and 8.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.
The emergence of obesity as a global epidemic is anticipated to create strong demand for body composition analyzers. With increasing cases of obesity, around 47%, 35% and 39% of the population in the US, the UK and Mexico is estimated to be obese by 2030.
The growing prevalence of obesity among adults and children can be credited to factors including sedentary lifestyles, hypertension, high blood lipids and diabetes mellitus. These incidents along with rising awareness about healthy lifestyles are expected to provide a major impetus to the global market for body composition analyzers.
As more number of people turn towards fitness approaches to shed excess weight, and stay fit and active, demand for solutions that assist in determining metabolic rate and calorie calculations is expected to surge in the following years. Body composition analyzers are used to determine the risk of specific conditions related to obesity.
For instance, capacitive and impedance analyzers are capable of producing values for individuals on the basis of their ethnicity and age. The trend is driving the demand for these devices in various applications in the field of medical research, sports and research projects related to epidemiology, nutrition and anthropology. The market is anticipated to receive a major impetus from the sports industry due to increasing adoption of body composition analyzers.
With the concepts of wellness and mindfulness becoming ever more important for consumers, fitness has become a more relevant goal for many people. The health and fitness industry in the US witnessed a steady pace of growth over the years. Currently, nearly 20% of adults in the US hold a fitness club membership. In addition to growing health consciousness, rise in per capita disposable income is a key factor driving growth in the space.
The increase in time spent on leisure and sports is also expected to expand the potential pool of consumers and thus demand for fitness centers. This in turn bodes well for body composition analyzers. The emerging demand for results-driven fitness centers that aid in achieving individual fitness goals is also expected to augment growth.
Increasing Number of Weight Loss Clinics, Sports Rehabilitation Centers, and Fitness Clubs to Drive Growth
As more number of people turn towards fitness approaches to shed excess weight, and stay fit and active, demand for solutions that assist in determining metabolic rate and calorie calculations is expected to surge in the following years. Body composition analyzers are used to determine the risk of specific conditions related to obesity.
For instance, capacitive and impedance analyzers are capable of producing values for individuals on the basis of their ethnicity and age. The trend is driving the demand for these devices in various applications in the field of medical research, sports and research projects related to epidemiology, nutrition and anthropology. The market is anticipated to receive a major impetus from the sports industry due to increasing adoption of body composition analyzers.
With the concepts of wellness and mindfulness becoming ever more important for consumers, fitness has become a more relevant goal for many people. The health and fitness industry in the US witnessed a steady pace of growth over the years. Currently, nearly 20% of adults in the US hold a fitness club membership.
In addition to growing health consciousness, rise in per capita disposable income is a key factor driving growth in the space. The increase in time spent on leisure and sports is also expected to expand the potential pool of consumers and thus demand for fitness centers. This in turn bodes well for body composition analyzers. The emerging demand for results-driven fitness centers that aid in achieving individual fitness goals is also expected to augment growth.
What`s New for 2022?
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies – Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to the digital archives
Complimentary updates for one year
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Underlying Conditions among Hospitalized COVID-19 Patients
Severely Obese People Face High Risk of Serious COVID-19 Outcomes
COVID-19 Pandemic Adds to the Healthcare Burden of Nations Worldwide
Endemic Lifestyle Diseases: Cornerstone to Growth of Body Composition Analyzers Market
Bio-Impedance Analyzer Segment to Command Major Share
Product Segment Definitions
Geographic Market Analysis
Recent Market Activity
Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS (Total 87 Featured)
AccuFitness, LLC
Beurer GmbH
Bodystat Limited
COSMED srl
GE Healthcare
Hologic, Inc.
InBody Co., Ltd
Maltron International Ltd.
Omron Corporation
RJL Systems, Inc.
Seca GmbH&Co. KG
Selvas Healthcare lnc.
Tanita Corporation
3. MARKET TRENDS & DRIVERS
Rise in Prevalence of Obesity Spurs Growth
Obesity Statistics
Increasing Number of Weight Loss Clinics, Sports Rehabilitation Centers, and Fitness Clubs to Drive Market Growth
Technology Developments Support Market Growth
Bathroom Scales Integrated with Body Fat Analyzers Gain Popularity
BIA Based Devices Gain Traction for Home Base Body Fat Monitoring
Costs and Accuracy Benefits Drive Demand for BIA
Segmental Bioimpedance Gains Traction in Body Composition Analysis
Increasing Osteoporisis Rates Trigger Demand
Aging Population and Growing Incidence of Targeted Conditions Drive Demand for Body composition Analyzers
4. GLOBAL MARKET PERSPECTIVE
III. REGIONAL MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/y7suai
Attachment
Global Market for Body Composition Analyzers
For generations, people labored until they hit retirement age, got an office party and maybe a watch on their last day, and then walked off into the sunset of retirement — but for many, it was more…
SIGA has received $60 million in orders for Tpoxx, which was developed to treat smallpox in the event of an attack.
Sorrento Therapeutics' (SRNE) stock rises after it announced positive results from its late-stage lung cancer study evaluating abivertinib.
By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT ORA-D-013-1 enrollment surpassed targeted participation… Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) has multiple clinical development programs underway. ORMD-0801, ORMP’s lead development candidate, is being tested in diabetes and NASH. In dual concurrent Phase 3 studies of ORMD-0801 for the treatment of T2D, enrollments for ORA-D-013-1
Pfizer's COVID antiviral Paxlovid appears to have little or no benefit for younger adults, although it still reduces the risk of hospitalization or death in seniors, according to a new Israeli study.
Cerevel Therapeutics more than doubled its cash balance to keep pace with Karuna Therapeutics in a head-to-head showdown.
Amazon shifts its emphasis as it plans to halt one of its key health initiatives by the end of 2022.
By John Vandermosten, CFA NYSE:CVM READ THE FULL CVM RESEARCH REPORT Third Quarter Fiscal Year 2022 Financial Results On August 15, 2022, CEL-SCI Corporation (NYSE:CVM) submitted its 3Q:22 Form 10-Q with the SEC concurrent with a press release announcing fiscal year 2022 third quarter results. Since our last update in June, CEL-SCI announced the appointment of Dr. Gail Naughton, a founder and
Come and meet extraordinary cannabis visionaries like Wana Brands' Nancy Whiteman and let’s network and learn together. Join us on September 13 & 14 at the Benzinga Cannabis Capital Conference and stay at the historic Palmer House Hotel. Don't miss out on a chance to hear about future market forecasts and worldly advice on investing and finance from those embedded in the cannabis industry. Ready, set, go! Book your tickets HERE, and your room HERE. Transcript (auto-generated) cannabis for health
Planet Fitness stock is a Buy as people return to the gym, said an analyst from Jefferies, who called the at-home-fitness craze a thing of the past. Jefferies analyst Randal Konik wrote Thursday that dismal earnings and a bleak forecast from Peloton Interactive (ticker: PTON) were proof that “consumers are headed back to the gyms, and in-home fitness is continuing to fade.” Peloton was a winner during the height of Covid-19 since it offered exercisers the ability to feel like they were getting a gym-like workout while they stayed indoors during pandemic-enforced lockdowns.
Amazon is shutting down the hybrid virtual, in-home care service it’s spent years developing, a surprising move that underscores the challenges it faces as it moves into health care. The service, called Amazon Care, will end by Dec. 31, according to an email sent to staff by Neil Lindsay, senior vice president of Amazon Health Services. Amazon Care was launched in 2019 for Seattle-based Amazon’s Washington state employees, who served as trial users before the company made it available last year to its workers in all 50 states.
The Japanese Ministry of Health, Labour, and Welfare approved AstraZeneca's (AZN) three marketed drugs, Lynparza, Tagrisso and Ultomiris, for three different indications in Japan.
The FDA let manufacturers apply without clinical trial data to “get ahead of” variants.
If you did go, the tools the hygienist used, the plastic cup you reached for when told to rinse, and the loupe the dentist used to peer into your mouth all might have come from Henry Schein, too. The Long Island, N.Y.-based distributor counts 90% of U.S. dental practices as its customers, and says that it accounts for between 35% and 40% of the North American market for dental supplies. Its dental business also has a significant presence in Europe, Australia and New Zealand.
Abbott's (ABT) Proclaim Plus SCS system with FlexBurst360 therapy will cater to the changing needs of patients with chronic pain.
By Ernest Dela Aglanu, Benzinga
Statins provide limited use unless patients stay on them for life, research suggests.
AbbVie (ABBV) and J&J's (JNJ) Imbruvica gets FDA nod for label expansion to treat pediatric patients with chronic graft versus host disease. It is also the first BTK inhibitor approved for use in pediatric patients
South Carolina state Rep. Neal Collins said he didn't sleep "that whole week" after hearing the effect strict anti-abortion bills can have on real people.
A new federal report from the National Institutes of Health about marijuana shows the number of young people using pot has jumped to historic highs.
